OQS
ADMA icon

Occudo Quantitative Strategies’s ADMA Biologics ADMA Stock Holding History

Occudo Quantitative Strategies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,453
Closed -$75.6K – 724
2024
Q1 		$75.6K Sell
11,453
-187,368
-94% -$1.02M 0.01% 676
2023
Q4 		$899K Buy
+198,821
New +$736K 0.12% 235
2023
Q3 		– Sell
-141,556
Closed -$522K – 932
2023
Q2 		$522K Buy
141,556
+26,862
+23% +$99.6K 0.05% 538
2023
Q1 		$380K Sell
114,694
-33,080
-22% -$114K 0.03% 591
2022
Q4 		$573K Sell
147,774
-96,102
-39% -$296K 0.07% 459
2022
Q3 		$593K Buy
243,876
+208,757
+594% +$501K 0.05% 603
2022
Q2 		$70K Buy
+35,119
New +$69.1K 0.01% 1044

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Occudo Quantitative Strategies's ADMA Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of ADMA Biologics (ADMA) in Q2 2024, closing a stake of 11,453 shares — an estimated $75.6K sold.

Occudo Quantitative Strategies first reported a position in ADMA in Q2 2022 and held it in 7 quarters. The position peaked at $899K in Q4 2023. 252 funds tracked by Wall St. Rank hold ADMA as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining ADMA Biologics position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,453 ADMA Biologics shares in Q2 2024, an estimated $75.6K.
  • Occudo Quantitative Strategies first reported a position in ADMA Biologics in Q2 2022 and held it in 7 quarters.
  • Occudo Quantitative Strategies's ADMA Biologics position peaked at $899K in Q4 2023.
  • 252 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.